Literature DB >> 13923245

Eczema vaccinatum treated with n-methylisatin beta-thiosemicarbazone.

W TURNER, D J BAUER, R H NIMMO-SMITH.   

Abstract

Entities:  

Keywords:  INDOLES/therapy; THIOSEMICARBAZONES/therapy; VACCINIA/therapy

Mesh：

Substances：

Year:  1962        PMID： 13923245      PMCID： PMC1958745          DOI： 10.1136/bmj.1.5288.1317

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Inhibition of rabbitpox virus replication by isatin beta-thiosemicarbazone.

Authors:  F W SHEFFIELD
Journal:  Br J Exp Pathol       Date:  1962-02

2.  Antiviral chemotherapeutic activity of isatin beta-thiosemicarbazone in mice infected with rabbit-pox virus.

Authors:  D J BAUER; F W SHEFFIELD
Journal:  Nature       Date:  1959-11-07       Impact factor: 49.962

3.  The antiviral and synergic actions of isatin thiosemicarbazone and certain phenoxypyrimidines in vaccinia infection in mice.

Authors:  D J BAUER
Journal:  Br J Exp Pathol       Date:  1955-02
  3 in total
  8 in total

1.  Prolonged generalized vaccinia complicating acute leukaemia.

Authors:  E DAVIDSON; F G HAYHOE
Journal:  Br Med J       Date:  1962-11-17

2.  Vaccinia gangrenosa treated with N-methylisatin beta-thiosemicarbazone.

Authors:  J J DALY; E JACKSON
Journal:  Br Med J       Date:  1962-11-17

3.  A case of vaccinia necrosum (or progressive vaccinia), with severe hypogammaglobulinaemia, treated with n-methyl isatin beta-thiosemicarbazone (33T57).

Authors:  T H FLEWETT; F L KER
Journal:  J Clin Pathol       Date:  1963-05       Impact factor: 3.411

4.  Pilot trial of an antiviral agent in malignant disease.

Authors:  T F Sandeman
Journal:  Br Med J       Date:  1966-09-10

5.  Treatment with methisazone of complications following smallpox vaccination.

Authors:  B Jaroszyńska-Weinberger
Journal:  Arch Dis Child       Date:  1970-08       Impact factor: 3.791

6.  Problems of smallpox immunization.

Authors:  A L Libov
Journal:  Indian J Pediatr       Date:  1967-12       Impact factor: 1.967

7.  Inhibition of RNA-dependent DNA polymerase of Rous sarcoma virus by thiosemicarbazones and several cations.

Authors:  W Levinson; A Faras; B Woodson; J Jackson; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

Review 8.  From actually toxic to highly specific--novel drugs against poxviruses.

Authors:  Katja Sliva; Barbara Schnierle
Journal:  Virol J       Date:  2007-01-15       Impact factor: 4.099
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.